119 related articles for article (PubMed ID: 31561045)
1. Discovery of 2-isoxazol-3-yl-acetamide analogues as heat shock protein 90 (HSP90) inhibitors with significant anti-HIV activity.
Trivedi J; Parveen A; Rozy F; Mitra A; Bal C; Mitra D; Sharon A
Eur J Med Chem; 2019 Dec; 183():111699. PubMed ID: 31561045
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and anti-HIV activity of a new isoxazole containing disubstituted 1,2,4-oxadiazoles analogs.
Kumar Kushwaha P; Saurabh Srivastava K; Kumari N; Kumar R; Mitra D; Sharon A
Bioorg Med Chem; 2022 Feb; 56():116612. PubMed ID: 35026631
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and anti-HIV activity evaluation of 2-(4-(naphthalen-2-yl)-1,2,3-thiadiazol-5-ylthio)-N-acetamides as novel non-nucleoside HIV-1 reverse transcriptase inhibitors.
Zhan P; Liu X; Fang Z; Li Z; Pannecouque C; De Clercq E
Eur J Med Chem; 2009 Nov; 44(11):4648-53. PubMed ID: 19628308
[TBL] [Abstract][Full Text] [Related]
4. Arylazolylthioacetanilide. Part 8: Design, synthesis and biological evaluation of novel 2-(2-(2,4-dichlorophenyl)-2H-1,2,4-triazol-3-ylthio)-N-arylacetamides as potent HIV-1 inhibitors.
Zhan P; Chen X; Li X; Li D; Tian Y; Chen W; Pannecouque C; De Clercq E; Liu X
Eur J Med Chem; 2011 Oct; 46(10):5039-45. PubMed ID: 21872971
[TBL] [Abstract][Full Text] [Related]
5. Preliminary SAR and biological evaluation of potent HIV-1 protease inhibitors with pyrimidine bases as novel P2 ligands to enhance activity against DRV-resistant HIV-1 variants.
Zhu M; Ma L; Zhou H; Dong B; Wang Y; Wang Z; Zhou J; Zhang G; Wang J; Liang C; Cen S; Wang Y
Eur J Med Chem; 2020 Jan; 185():111866. PubMed ID: 31734023
[TBL] [Abstract][Full Text] [Related]
6. Novel 1,2,3-thiadiazole derivatives as HIV-1 NNRTIs with improved potency: Synthesis and preliminary SAR studies.
Zhan P; Liu X; Li Z; Fang Z; Li Z; Wang D; Pannecouque C; Clercq ED
Bioorg Med Chem; 2009 Aug; 17(16):5920-7. PubMed ID: 19620009
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Hepatitis C Replication by Targeting the Molecular Chaperone Hsp90: Synthesis and Biological Evaluation of 4,5,6,7-Tetrahydrobenzo[1,2-d]thiazole Derivatives.
Lillsunde KE; Tomašič T; Schult P; Lohmann V; Kikelj D; Tammela P
ChemMedChem; 2019 Feb; 14(3):334-342. PubMed ID: 30548820
[TBL] [Abstract][Full Text] [Related]
8. A novel isothiocyanate derivative inhibits HIV-1 gene expression and replication by modulating the nuclear matrix associated protein SMAR1.
Trivedi J; Alam A; Joshi S; Kumar TP; Chippala V; Mainkar PS; Chandrasekhar S; Chattopadhyay S; Mitra D
Antiviral Res; 2020 Jan; 173():104648. PubMed ID: 31706900
[TBL] [Abstract][Full Text] [Related]
9. Symmetrical 1-pyrrolidineacetamide showing anti-HIV activity through a new binding site on HIV-1 integrase.
Du L; Zhao YX; Yang LM; Zheng YT; Tang Y; Shen X; Jiang HL
Acta Pharmacol Sin; 2008 Oct; 29(10):1261-7. PubMed ID: 18817633
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of 2-(2,6-dibromophenyl)-3-heteroaryl-1,3-thiazolidin-4-ones as anti-HIV agents.
Rawal RK; Tripathi R; Katti SB; Pannecouque C; De Clercq E
Eur J Med Chem; 2008 Dec; 43(12):2800-6. PubMed ID: 18242784
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and anti-human immunodeficiency virus type 1 activity of (E)-N-phenylstyryl-N-alkylacetamide derivatives.
Cheng P; Chen JJ; Huang N; Wang RR; Zheng YT; Liang YZ
Molecules; 2009 Aug; 14(9):3176-86. PubMed ID: 19783916
[TBL] [Abstract][Full Text] [Related]
12. Arylazolyl(azinyl)thioacetanilides. Part 16: Structure-based bioisosterism design, synthesis and biological evaluation of novel pyrimidinylthioacetanilides as potent HIV-1 inhibitors.
Li X; Lu X; Chen W; Liu H; Zhan P; Pannecouque C; Balzarini J; De Clercq E; Liu X
Bioorg Med Chem; 2014 Oct; 22(19):5290-7. PubMed ID: 25150090
[TBL] [Abstract][Full Text] [Related]
13. The structure-activity relationships of 2,4(1H,3H)-pyrimidinedione derivatives as potent HIV type 1 and type 2 inhibitors.
Buckheit RW; Hartman TL; Watson KM; Kwon HS; Lee SH; Lee JW; Kang DW; Chung SG; Cho EH
Antivir Chem Chemother; 2007; 18(5):259-75. PubMed ID: 18046959
[TBL] [Abstract][Full Text] [Related]
14. Discovery of 2-pyridone derivatives as potent HIV-1 NNRTIs using molecular hybridization based on crystallographic overlays.
Chen W; Zhan P; Rai D; De Clercq E; Pannecouque C; Balzarini J; Zhou Z; Liu H; Liu X
Bioorg Med Chem; 2014 Mar; 22(6):1863-72. PubMed ID: 24581546
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and biological evaluation of substituted (+)-SG-1 derivatives as novel anti-HIV agents.
Liu X; Chen P; Li X; Ba M; Jiao X; Guo Y; Xie P
Bioorg Med Chem Lett; 2018 Jun; 28(10):1699-1703. PubMed ID: 29699924
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and anti-HIV activity of some [Nucleoside Reverse Transcriptase Inhibitor]-C5'-linker-[Integrase Inhibitor] heterodimers as inhibitors of HIV replication.
Sugeac E; Fossey C; Ladurée D; Schmidt S; Laumond G; Aubertin AM
J Enzyme Inhib Med Chem; 2004 Dec; 19(6):497-509. PubMed ID: 15662954
[TBL] [Abstract][Full Text] [Related]
17. Characterization of New Cationic N,N-Dimethyl[70]fulleropyrrolidinium Iodide Derivatives as Potent HIV-1 Maturation Inhibitors.
Castro E; Martinez ZS; Seong CS; Cabrera-Espinoza A; Ruiz M; Hernandez Garcia A; Valdez F; Llano M; Echegoyen L
J Med Chem; 2016 Dec; 59(24):10963-10973. PubMed ID: 28002960
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic analysis of the sensitivity of HIV-1 to inhibitors of the reverse transcriptase, protease, and integrase using a self-inactivating virus vector system.
Jármy G; Heinkelein M; Weissbrich B; Jassoy C; Rethwilm A
J Med Virol; 2001 Jul; 64(3):223-31. PubMed ID: 11424108
[TBL] [Abstract][Full Text] [Related]
19. Molecular design, synthesis and biological evaluation of BP-O-DAPY and O-DAPY derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitors.
Yang S; Pannecouque C; Daelemans D; Ma XD; Liu Y; Chen FE; De Clercq E
Eur J Med Chem; 2013 Jul; 65():134-43. PubMed ID: 23707918
[TBL] [Abstract][Full Text] [Related]
20. Discovery of potent HIV-1 non-nucleoside reverse transcriptase inhibitors from arylthioacetanilide structural motif.
Li W; Li X; De Clercq E; Zhan P; Liu X
Eur J Med Chem; 2015 Sep; 102():167-79. PubMed ID: 26276432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
